Inventor · disambiguated record
Xiaofan Li
Also filed as: LI XIAOFAN
10 granted patents·15 pending applications·24 citations·filing 2015–2024
84Inventor score
Files withSUTRO BIOPHARMA INC20MERCK SHARP & DOHME LLC2CELGENE CORP1MERCK PATENT GMBH1STURO BIOPHARMA INC1
Top patents by PatentIndex Score
25 records- 0194US10596270B2Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugatesSUTRO BIOPHARMA INC·Filed 2018·Granted Mar 24, 2020·15 cites·24 claims
- 0292US11744876B2Immunomodulator antibody drug conjugates and uses thereofSUTRO BIOPHARMA INC·Filed 2020·Granted Sep 5, 2023·4 cites·47 claims
- 0382US11708413B2Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2017·Granted Jul 25, 2023·3 cites·29 claims
- 0482US2025090676A1Anti-folate receptor alpha antibody conjugates and their usesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0577US12144869B2Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2023·Granted Nov 19, 2024·0 cites·24 claims
- 0677US2025135025A1Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugatesSTURO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0777US2025018054A1Anti-ror1 antibody conjugates, compositions comprising anti ror1 antibody conjugates, and methods of making and using anti-ror1 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 0875US12226490B2Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary classSUTRO BIOPHARMA INC·Filed 2023·Granted Feb 18, 2025·0 cites·38 claims
- 0974US11993658B2Anti-BCMA antibodies and treatment methodsSUTRO BIOPHARMA INC·Filed 2019·Granted May 28, 2024·1 cites·16 claims
- 1073US2024409630A1Anti-folate receptor antibodies, compositions comprising anti-folate receptor antibodies and methods of making and using anti-folate receptor antibodiesSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1172US12427201B2Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugatesSUTRO BIOPHARMA INC·Filed 2019·Granted Sep 30, 2025·0 cites·27 claims
- 1271US10975150B2Anti-CD74 antibodies, compositions comprising anti-CD74 antibodies and methods of using anti-CD74 antibodiesSUTRO BIOPHARMA INC·Filed 2015·Granted Apr 13, 2021·1 cites·29 claims
- 1371US2024182580A1Anti-cd74 antibody conjugates, compositions comprising anti cd74 antibody conjugates and methods of using anti-cd74 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1471US2024101631A1Human interleukin-2 conjugates biased for the interleukin-2 receptor beta-gammac dimer and conjugated to a nonpeptidic, water-soluble polymerMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1570US2024368295A1Anti-bcma antibodies and treatment methodsSUTRO BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1669US2024139285A1Immunomodulator antibody drug conjugates and uses thereofSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1769US2025236674A9Anti-cd74 antibody conjugates, compositions comprising anti cd74 antibody conjugates and methods of using anti-cd74 antibody conjugatesSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 1868US12071477B2Anti-folate receptor alpha antibody conjugated with hemiasterlinsSUTRO BIOPHARMA INC·Filed 2018·Granted Aug 27, 2024·0 cites·26 claims
- 1965US11827684B2Human interleukin-2 conjugates biased for the interleukin-2 receptor beta GAMMAc dimer and conjugated to a nonpeptidic, water-soluble polymerMERCK SHARP & DOHME LLC·Filed 2021·Granted Nov 28, 2023·0 cites·54 claims
- 2063US2024124585A1Anti-cd3 antibodies, compositions comprising anti-cd3 antibodies and methods of making and using anti-cd3 antibodiesSUTRO BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2161US2021284739A1Anti-cd74 antibodies, compositions comprising anti-cd74 antibodies and methods of using anti-cd74 antibodiesSUTRO BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 2254US2019233512A1Anti-folate receptor antibodies, compositions comprising anti-folate receptor antibodies and methods of making and using anti-folate receptor antibodiesSUTRO BIOPHARMA INC·Filed 2017·Application pending·0 cites
- 2352US2023310629A1Bispecific antibody-drug conjugates targeting egfr and muc1 and uses thereofMERCK PATENT GMBH·Filed 2021·Application pending·0 cites
- 2448US2022323599A1Anti-bcma antibody conjugate, compositions comprising the same, and methods of making and using the sameCELGENE CORP·Filed 2020·Application pending·0 cites
- 2547US2022362394A1Anti-bcma antibody conjugatesSUTRO BIOPHARMA INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaofan Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →